Robert Lisicki
Net Worth

Last updated:

What is Robert Lisicki net worth?

The estimated net worth of Mr. Robert Lisicki is at least $11,585,541 as of 3 Aug 2021. He owns shares worth $1,609,939 as insider, has earned $5,855,822 from insider trading and has received compensation worth at least $4,119,780 in Arena Pharmaceuticals, Inc..

What is the salary of Robert Lisicki?

Mr. Robert Lisicki salary is $686,630 per year as Executive Vice President & Chief Commercial Officer in Arena Pharmaceuticals, Inc..

How old is Robert Lisicki?

Mr. Robert Lisicki is 57 years old, born in 1968.

What stocks does Robert Lisicki currently own?

As insider, Mr. Robert Lisicki owns shares in one company:

Company Title Shares Price per share Total value
Arena Pharmaceuticals, Inc. (ARNA) Executive Vice President & Chief Commercial Officer 16,101 $99.99 $1,609,939

What does Arena Pharmaceuticals, Inc. do?

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

ARNA logo
ARNA
Arena Pharmaceuticals, Inc.
$99.99

Robert Lisicki insider trading

Arena Pharmaceuticals, Inc.

Mr. Robert Lisicki has made 7 insider trades between 2019-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 30,000 units of ARNA stock on 4 Aug 2020. As of 3 Aug 2021 he still owns at least 16,101 units of ARNA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 17,500 $40.95 $716,625
Sale
Common Stock 17,500 $60.02 $1,050,350
Option
Employee Stock Option (right to buy) 17,500 $40.95 $716,625
Sale
Common Stock 17,500 $78.52 $1,374,048
Option
Common Stock 17,500 $40.95 $716,625
Option
Employee Stock Option (right to buy) 17,500 $40.95 $716,625
Sale
Common Stock 17,500 $52.07 $911,173
Option
Common Stock 12,600 N/A N/A
Option
Performance Restricted Stock Unit 12,600 N/A N/A
Sale
Common Stock 3,872 $43.64 $168,978
Sale
Common Stock 3,872 $65.88 $255,095
Option
Common Stock 6,300 N/A N/A
Option
Performance Restricted Stock Unit 6,300 N/A N/A
Sale
Common Stock 30,000 $63.11 $1,893,180
Option
Employee Stock Option (right to buy) 30,000 $40.95 $1,228,500
Option
Common Stock 30,000 $40.95 $1,228,500
Sale
Common Stock 4,429 $45.83 $202,999
Option
Performance Restricted Stock Unit 6,300 N/A N/A
Option
Common Stock 6,300 N/A N/A

Arena Pharmaceuticals key executives

Arena Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: